文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

实施高流量鼻导管后医护人员COVID-19感染未增加:一项安全性评价

No evidence of increasing COVID-19 in health care workers after implementation of high flow nasal cannula: A safety evaluation.
PubMed 文献 · Am J Emerg Med · 2020-10-07
一句话结论回顾性评价显示,在COVID-19患者中实施增加HFNC使用的呼吸方案后,医护人员COVID-19感染率未增加,但结果仅具假设生成性。

该研究为回顾性评价,分析2020年3月15日至5月23日某医疗系统员工COVID-19检测数据。实施增加HFNC使用的呼吸方案后,临床人员阳性比例(41.5%)不高于非临床人员(43.8%);在高风险COVID-19单元工作的临床人员中,方案实施后感染未见增加。结论为未发现HFNC使用增加导致医护人员感染增加的证据,但结果属假设生成性。

要点

  • 实施增加HFNC使用的COVID-19呼吸方案后,临床人员阳性比例41.5%不高于非临床人员43.8%。
  • 在高风险COVID-19单元工作的临床人员中,方案实施后感染相比未使用HFNC的COVID-19单元未见增加。
  • 医护人员暴露于HFNC治疗的COVID-19患者时佩戴N95/KN95口罩。
  • 作者结论为无感染增加证据,但结果仅具假设生成性。

适用人群与场景

  • 2020年3月15日至5月23日期间在某医疗系统接受COVID-19检测的员工,按临床或非临床角色及是否在COVID-19住院单元工作分层。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 对重症COVID-19患者实施呼吸方案,增加HFNC使用。
  • 暴露于HFNC治疗的COVID-19患者的医护人员佩戴N95/KN95口罩。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为回顾性评价,样本为1635名接受COVID-19检测的员工,其中228名(13.9%)阳性。
  • 方案实施后,临床人员阳性比例41.5%不高于非临床人员43.8%。
  • 在高风险COVID-19单元工作的临床人员中,方案实施后感染相比未使用HFNC的COVID-19单元未见增加。

证据类型、等级与局限

  • 证据类型为回顾性评价;作者指出结果仅具假设生成性(hypothesis generating)。
  • 原文未述其他局限性。

对床旁实践的改变

  • 在重症COVID-19患者中实施增加HFNC使用的呼吸方案,同时医护人员佩戴N95/KN95口罩,未观察到医护人员COVID-19感染增加。
  • 该结果仅具假设生成性,不能作为确定性结论推广。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Initial recommendations discouraged high flow nasal cannula (HFNC) in COVID-19 patients, driven by concern for healthcare worker (HCW) exposure. Noting high morbidity and mortality from early invasive mechanical ventilation, we implemented a COVID-19 respiratory protocol employing HFNC in severe COVID-19 and HCW exposed to COVID-19 patients on HFNC wore N95/KN95 masks. Utilization of HFNC increased significantly but questions remained regarding HCW infection rate.

METHODS: We performed a retrospective evaluation of employee infections in our healthcare system using the Employee Health Services database and unit records of employees tested between March 15, 2020 and May 23, 2020. We assessed the incidence of infections before and after the implementation of the protocol, stratifying by clinical or non-clinical role as well as inpatient COVID-19 unit.

RESULTS: During the study period, 13.9% (228/1635) of employees tested for COVID-19 were positive. Forty-six percent of infections were in non-clinical staff. After implementation of the respiratory protocol, the proportion of positive tests in clinical staff (41.5%) was not higher than that in non-clinical staff (43.8%). Of the clinicians working in the high-risk COVID-19 unit, there was no increase in infections after protocol implementation compared with clinicians working in COVID-19 units that did not use HFNC.

CONCLUSION: We found no evidence of increased COVID-19 infections in HCW after the implementation of a respiratory protocol that increased use of HFNC in patients with COVID-19; however, these results are hypothesis generating.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Westafer LM, Soares WE, Salvador D, et al. No evidence of increasing COVID-19 in health care workers after implementation of high flow nasal cannula: A safety evaluation. Am J Emerg Med. 2020. PMID: 33059983. doi:10.1016/j.ajem.2020.09.086

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。